Man, Terry. You and I have been kicking around these messages boards a long time now. Remember ID Biomedical around the turn of the century? I was friendotd. I think you were yahooing with me back then. Maybe some other companies... I haven't run across you in awhile but your writing style hasn't changed a bit - always leaving the reader guessing a little. What ever happened to the Al Greenspan gang?
Whether you want to call it a vaccine or not, someone is paying for trialing this DNA vax. But it shouldn't hold a candle to a Lm vac. It makes sense that eventually all manner of immune regulators will find synergistic uses. Vaccines paired with checkpoint drugs are kind of a no-brainer if they can keep the side effects reasonable.
Today we read a pair of abstracts about Lm v prostate cancer. My initial reaction was disappointment in that there were no CRs or PRs. Then I looked at the history and found that stable disease is about as good as it gets with prostate cancer immunotherapy. We ought to get some good ph2 results with this combo in a couple of years. Perhaps that, along with everything else, will finally get the share price up!
News 
Market Data 
Discover 
